Literature DB >> 19835018

Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.

Paul E Kalb, Paul E Greenberg.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19835018     DOI: 10.2165/11315660-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Off label use--label off use?

Authors:  J Boos
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

2.  Off-label prescribing in oncology.

Authors:  Susan G Poole; Michael J Dooley
Journal:  Support Care Cancer       Date:  2004-02-18       Impact factor: 3.603

3.  "Off-label" indications for oncology drug use and drug compendia: history and current status.

Authors: 
Journal:  J Oncol Pract       Date:  2005-09       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.